The density of macrophages in the invasive front is inversely correlated to liver metastasis in colon cancer

被引:166
作者
Zhou, Qiang [1 ,2 ]
Peng, Rui-Qing [1 ,2 ]
Wu, Xiao-Jun [3 ]
Xia, Qing [1 ,2 ]
Hou, Jing-Hui [4 ]
Ding, Ya [1 ,2 ]
Zhou, Qi-Ming [1 ,2 ]
Zhang, Xing [1 ,2 ]
Pang, Zhi-Zhong [3 ]
Wan, De-Sen [3 ]
Zeng, Yi-Xin [1 ,2 ]
Zhang, Xiao-Shi [1 ,2 ]
机构
[1] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510060, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Ctr Canc, Biotherapy Ctr, Guangzhou 510060, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Ctr Canc, Dept Colorectal Oncol, Guangzhou 510060, Guangdong, Peoples R China
[4] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou 510060, Guangdong, Peoples R China
来源
JOURNAL OF TRANSLATIONAL MEDICINE | 2010年 / 8卷
关键词
TUMOR-ASSOCIATED MACROPHAGES; HUMAN COLORECTAL-CANCER; CELL LUNG-CANCER; NF-KAPPA-B; INFILTRATING MACROPHAGES; T-CELLS; HEPATOCELLULAR-CARCINOMA; PROGNOSTIC-SIGNIFICANCE; SIGNIFICANT PREDICTOR; FAVORABLE PROGNOSIS;
D O I
10.1186/1479-5876-8-13
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Although an abundance of evidence has indicated that tumor-associated macrophages (TAMs) are associated with a favorable prognosis in patients with colon cancer, it is still unknown how TAMs exert a protective effect. This study examined whether TAMs are involved in hepatic metastasis of colon cancer. Materials and methods: One hundred and sixty cases of pathologically-confirmed specimens were obtained from colon carcinoma patients with TNM stage IIIB and IV between January 1997 and July 2004 at the Cancer Center of Sun Yat-Sen University. The density of macrophages in the invasive front (CD68TF(Hotspot)) was scored with an immunohistochemical assay. The relationship between the CD68TF(Hotspot) and the clinicopathologic parameters, the potential of hepatic metastasis, and the 5-year survival rate were analyzed. Results: TAMs were associated with the incidence of hepatic metastasis and the 5-year survival rate in patients with colon cancers. Both univariate and multivariate analyses revealed that the CD68TF(Hotspot) was independently prognostic of survival. A higher 5-year survival rate among patients with stage IIIB after radical resection occurred in patients with a higher macrophage infiltration in the invasive front (81.0%) than in those with a lower macrophage infiltration (48.6%). Most importantly, the CD68TF(Hotspot) was associated with both the potential of hepatic metastasis and the interval between colon resection and the occurrence of hepatic metastasis. Conclusion: This study showed evidence that TAMs infiltrated in the invasive front are associated with improvement in both hepatic metastasis and overall survival in colon cancer, implying that TAMs have protective potential in colon cancers and might serve as a novel therapeutic target.
引用
收藏
页数:9
相关论文
共 68 条
[1]   TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study [J].
Bacman, David ;
Merkel, Susanne ;
Croner, Roland ;
Papadopoulos, Thomas ;
Brueckl, Wolfgang ;
Dimmler, Arno .
BMC CANCER, 2007, 7 (1)
[2]   Relevance of biologic markers in colorectal carcinoma - A comparative study of a broad panel [J].
Barozzi, C ;
Ravaioli, M ;
D'Errico, A ;
Grazi, GL ;
Poggioli, G ;
Cavrini, G ;
Mazziotti, A ;
Grigioni, WF .
CANCER, 2002, 94 (03) :647-657
[3]   Biology of colorectal liver metastases: A review [J].
Bird, Nigel C. ;
Mangnall, David ;
Majeed, Ali W. .
JOURNAL OF SURGICAL ONCOLOGY, 2006, 94 (01) :68-80
[4]   Macrophages: Obligate partners for tumor cell migration, invasion, and metastasis [J].
Condeelis, J ;
Pollard, JW .
CELL, 2006, 124 (02) :263-266
[5]   Chemo-immunotherapy of metastatic colorectal carcinoma with gemcitabine plus FOLFOX 4 followed by subcutaneous granulocyte macrophage colony-stimulating factor and interleukin-2 induces strong immunologic and antitumor activity in metastatic colon cancer patients [J].
Correale, P ;
Cusi, MG ;
Tsang, KY ;
Del Vecchio, MT ;
Marsili, S ;
La Placa, M ;
Intrivici, C ;
Aquino, A ;
Micheli, L ;
Nencini, C ;
Ferrari, F ;
Giorgi, G ;
Bonmassar, E ;
Francini, G .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (35) :8950-8958
[6]   Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine plus FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 trial) [J].
Correale, Pierpaolo ;
Tagliaferri, Pierosandro ;
Fioravanti, Antonella ;
Del Vecchio, Maria Teresa ;
Remondo, Cinzia ;
Montagnani, Francesco ;
Rotundo, Maria Saveria ;
Ginanneschi, Chiara ;
Martellucci, Ignazio ;
Francini, Edoardo ;
Cusi, Maria Grazia ;
Tassone, Pierfrancesco ;
Francini, Guido .
CLINICAL CANCER RESEARCH, 2008, 14 (13) :4192-4199
[7]   Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells [J].
Dave, SS ;
Wright, G ;
Tan, B ;
Rosenwald, A ;
Gascoyne, RD ;
Chan, WC ;
Fisher, RI ;
Braziel, RM ;
Rimsza, LM ;
Grogan, TM ;
Miller, TP ;
LeBlanc, M ;
Greiner, TC ;
Weisenburger, DD ;
Lynch, JC ;
Vose, J ;
Armitage, JO ;
Smeland, EB ;
Kvaloy, S ;
Holte, H ;
Delabie, J ;
Connors, JM ;
Lansdorp, PM ;
Ouyang, Q ;
Lister, TA ;
Davies, AJ ;
Norton, AJ ;
Muller-Hermelink, HK ;
Ott, G ;
Campo, E ;
Montserrat, E ;
Wilson, WH ;
Jaffe, ES ;
Simon, R ;
Yang, LM ;
Powell, J ;
Zhao, H ;
Goldschmidt, N ;
Chiorazzi, M ;
Staudt, LM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (21) :2159-2169
[8]   CD4+ T Cells Regulate Pulmonary Metastasis of Mammary Carcinomas by Enhancing Protumor Properties of Macrophages [J].
DeNardo, David G. ;
Barreto, Jairo B. ;
Andreu, Pauline ;
Vasquez, Lesley ;
Tawfik, David ;
Kolhatkar, Nikita ;
Coussens, Lisa M. .
CANCER CELL, 2009, 16 (02) :91-102
[9]   High tumor-infiltrating macrophage density predicts poor prognosis in patients with primary hepatocellular carcinoma after resection [J].
Ding, Tong ;
Xu, Jing ;
Wang, Fang ;
Shi, Ming ;
Zhang, Ying ;
Li, Sheng-Ping ;
Zheng, Limin .
HUMAN PATHOLOGY, 2009, 40 (03) :381-389
[10]   Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use [J].
Duffy, M. J. ;
van Dalen, A. ;
Haglund, C. ;
Hansson, L. ;
Holinski-Feder, E. ;
Klapdor, R. ;
Lamerz, R. ;
Peltomaki, P. ;
Sturgeon, C. ;
Topolcan, O. .
EUROPEAN JOURNAL OF CANCER, 2007, 43 (09) :1348-1360